ANI PHARMACEUTICALS INC's ticker is and the CUSIP is 00182CAA1. A total of 21 filers reported holding ANI PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $22,554,000 | +31.0% | 20,719,000 | +45.7% | 0.02% | +28.6% |
| Q2 2019 | $17,223,000 | +1091.9% | 14,219,000 | +981.3% | 0.01% | +1300.0% |
| Q1 2019 | $1,445,000 | +1560.9% | 1,315,000 | +1411.5% | 0.00% | – |
| Q4 2018 | $87,000 | -5.4% | 87,000 | 0.0% | 0.00% | – |
| Q3 2018 | $92,000 | -50.3% | 87,000 | -48.5% | 0.00% | – |
| Q1 2018 | $185,000 | -86.3% | 169,000 | -85.6% | 0.00% | -100.0% |
| Q4 2017 | $1,347,000 | +1.8% | 1,173,000 | -3.8% | 0.00% | 0.0% |
| Q3 2017 | $1,323,000 | +435.6% | 1,219,000 | +418.7% | 0.00% | – |
| Q2 2017 | $247,000 | -74.3% | 235,000 | -74.2% | 0.00% | -100.0% |
| Q1 2017 | $961,000 | +96000.0% | 911,000 | +91000.0% | 0.00% | – |
| Q4 2016 | $1,000 | -98.4% | 1,000 | -98.0% | 0.00% | – |
| Q3 2016 | $62,000 | -90.0% | 50,000 | -92.6% | 0.00% | -100.0% |
| Q3 2015 | $620,000 | -15.4% | 673,000 | +4.7% | 0.00% | 0.0% |
| Q2 2015 | $733,000 | – | 643,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wellesley Asset Management | 59,455 | $68,522,000 | 3.54% |
| DLD Asset Management, LP | 4,500,000 | $5,185,000 | 1.70% |
| Worth Venture Partners, LLC | 945,000 | $1,100,000 | 1.18% |
| Perceptive Advisors | 7,500,000 | $8,700,000 | 0.62% |
| WOLVERINE ASSET MANAGEMENT LLC | 15,439,000 | $17,789,000 | 0.23% |
| Allianz Asset Management GmbH | 35,165,000 | $40,795,000 | 0.04% |
| GABELLI FUNDS LLC | 1,500,000 | $1,740,000 | 0.01% |
| AQR Arbitrage LLC | 525,000 | $605,000 | 0.01% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 9,000,000 | $10,328,000 | 0.01% |
| Edge Advisors, LLC | 33,000 | $38,000 | 0.01% |